Piceatannol

Supplement

Piceatannol is retained as a catalog identity with independently verified primary-literature context. No qualified exposure model, dose recommendation, efficacy claim, or safety claim is provided.

Pharmacokinetic model

A route-level PK model for piceatannol is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.

Key facts

Category
Supplement
Suggested cadence
once daily

Research behind this entry

  1. Piceatannol, a natural hydroxylated analog of resveratrol, promotes nitric oxide release through phosphorylation of endothelial nitric oxide synthase in human endothelial cells. Son Y, Lee JH, Cheong YK, Jung HC, Jeong SO, Park SH, Pae HO · European review for medical and pharmacological sciences, 2015

    This citation reports a laboratory or cell study involving Piceatannol. It does not establish a qualified human dose, safety profile, efficacy claim, or pharmacokinetic route for this catalog record.

1 published study referenced in the app, each with a plain-language summary.